Nuvia Nabs $240 Million Series B
|Mithril Capital led Nuvia’s Series B funding in partnership with semiconductor veterans Sehat Sutardja (pictured) and Weili Dai.
Photo by Sikarin Thanachaiary, licensed under Creative Commons
Nuvia, a Santa Clara-based silicon design upstart founded by former Apple and Google veterans, has announced that it’s closed $240 million in Series B funding led by venture capital firm Mithril Capital, with participation from other investors including BlackRock, Fidelity, Dell Technologies Capital, Mayfield, Atlantic Bridge, and Redline Capital. The Series B fundraise follows a $53 million Series A raised by Nuvia in November of last year, on the heels of the company’s founding. The new investment has apparently boosted the total amount of funding that Nuvia has raised since its founding just a year ago to nearly $300 million. The valuation that came with the new funding isn’t disclosed.
Nuvia’s new fundraise was actually led by Mithril Capital in partnership with two silicon design veterans by the names of Sehat Sutardja and Weili Dai, best known as the couple who founded semiconductor powerhouse Marvell Technology Group. Both individuals are veterans of the semiconductor industry, with an experience that comes in handy for Nuvia, which is a relatively new upstart in the industry. Nuvia was founded last year by three chip design veterans by the names of John Bruno, Manu Gulati, and Gerard Williams. Williams, who serves as CEO, was a former top chip designer at Apple, where he served as the chief architect for the company’s iPhone and iPad chips. He made headlines late last year when Apple launched a suit against him over allegations of breaking his employment agreement while he worked at the company. In response, Williams filed a countersuit, with the case still ongoing.
Nuvia is working on a new type of system on a chip (SoC) and CPU for computers, respectively codenamed “Orion” and “Phoenix”. Being a relatively new startup, not much has been dished out about the company’s intended product and the progress on its development.